Monocular Compound Microscope

All about monocular compound microscope
Monocular Compound Microscope Resources

Home > Monocular Compound Microscope > Omrix Biopharmaceuticals Initiates Phase II Clinical Trial In Israel For Fibrin Pad Product Candidate

Omrix Biopharmaceuticals Initiates Phase II Clinical Trial In Israel For Fibrin Pad Product Candidate




Omrix Biopharmaceuticals, Inc. ("Omrix" or the "Company") (NASDAQ: OMRI) announced that it has enrolled its first patient in a Phase II clinical trial in Israel for its Fibrin Pad product candidate. This is the first clinical trial that will evaluate the Fibrin Pad's performance in surgery where severe bleeding is present and the product is applied directly onto a solid organ. The Phase II clinical trial in Israel is being conducted simultaneously with the Phase II clinical trial in the U.S.


Click Here to read the entire article...




Other Articles:


Stimuli-responsive polymers: Engineering interactions
Materials that respond to their external environment require creative molecular design ? much inspiration comes from the natural world.
Click Here to read the entire article...
First DNA Molecule Made Almost Entirely Of Artificial Parts
Chemists in Japan report development of the world's first DNA molecule made almost entirely of artificial parts. The finding could lead to improvements in gene therapy, futuristic nano-sized computers, and other high-tech advances, they say. 
Click Here to read the entire article...
Can you really run car with water?
Can we run our car with water and gas?
Can anybody tell me is the HHO Gas is real working or is another scam?
Click Here to read the entire article...
Xceed Molecular Grants Gen-Probe License to Xceed's Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
Click Here to read the entire article...
Protecting Romaine Lettuce From Pathogens
Knowing the preferences of foodborne pathogens such as Escherichia coli O157:H7 is essential to a successful counterattack on these microbes. That's why microbiologists are scrutinizing the little-understood ability of E. coli O157:H7 and Salmonella enterica to contaminate romaine lettuce.
Click Here to read the entire article...
Dan Gerding, Managing Principal, Gerding Collaborative, 7-26-07
Sustainable design, restorative design, architecture, triple bottom line. Gerding Collaborative seeks ecologically sensitive solutions that promote responsible use of energy, land, and water resources for commercial, institutional, and residential clients. More than 70 percent of the firm's technical staff is LEED accredited. Dan Gerding has 23 years of professional experience, and has long held a keen interest in conservation and environmental responsibility.
Click Here to read the entire article...
Medical Devices News From Medical News Today
By editors@medicalnewstoday.com (MNT Editors) - Copyright 2008 Medical News Today - version: v1.5 build A